DK1732922T3 - Fremgangsmåde til minimering af thioamidurenheder - Google Patents

Fremgangsmåde til minimering af thioamidurenheder

Info

Publication number
DK1732922T3
DK1732922T3 DK05738187T DK05738187T DK1732922T3 DK 1732922 T3 DK1732922 T3 DK 1732922T3 DK 05738187 T DK05738187 T DK 05738187T DK 05738187 T DK05738187 T DK 05738187T DK 1732922 T3 DK1732922 T3 DK 1732922T3
Authority
DK
Denmark
Prior art keywords
minimizing
thioamide
thioamide impurities
impurities
thionations
Prior art date
Application number
DK05738187T
Other languages
Danish (da)
English (en)
Inventor
Bogdan Kazimierz Wilk
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Application granted granted Critical
Publication of DK1732922T3 publication Critical patent/DK1732922T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Glass Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK05738187T 2004-04-08 2005-04-07 Fremgangsmåde til minimering af thioamidurenheder DK1732922T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US56040304P 2004-04-08 2004-04-08
PCT/US2005/013657 WO2005100347A1 (en) 2004-04-08 2005-04-07 Methods for minimizing thioamide impurities

Publications (1)

Publication Number Publication Date
DK1732922T3 true DK1732922T3 (da) 2009-01-12

Family

ID=34966434

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05738187T DK1732922T3 (da) 2004-04-08 2005-04-07 Fremgangsmåde til minimering af thioamidurenheder

Country Status (14)

Country Link
US (2) US7314932B2 (cg-RX-API-DMAC7.html)
EP (1) EP1732922B1 (cg-RX-API-DMAC7.html)
JP (1) JP4950027B2 (cg-RX-API-DMAC7.html)
CN (1) CN1938298B (cg-RX-API-DMAC7.html)
AT (1) ATE409699T1 (cg-RX-API-DMAC7.html)
AU (1) AU2005233648B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0509213A (cg-RX-API-DMAC7.html)
CA (1) CA2561313C (cg-RX-API-DMAC7.html)
DE (1) DE602005010065D1 (cg-RX-API-DMAC7.html)
DK (1) DK1732922T3 (cg-RX-API-DMAC7.html)
ES (1) ES2313334T3 (cg-RX-API-DMAC7.html)
MX (1) MXPA06011695A (cg-RX-API-DMAC7.html)
PL (1) PL1732922T3 (cg-RX-API-DMAC7.html)
WO (1) WO2005100347A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4950027B2 (ja) 2004-04-08 2012-06-13 ワイス・エルエルシー チオアミド不純物を最小限に抑えるための方法
EP1732921B1 (en) * 2004-04-08 2008-11-05 Wyeth Thioamide derivatives as progesterone receptor modulators
US20090170823A1 (en) * 2007-12-20 2009-07-02 Duramed Pharmaceuticals, Inc. Dosage Regimens and Pharmaceutical Compositions and Packages for Emergency Contraception

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8308064D0 (en) * 1983-03-24 1983-05-05 Beecham Group Plc Active compounds
US4997950A (en) * 1989-04-20 1991-03-05 Richard Finbar Murphy Novel C-terminal gastrin antagonists
JPH0834775A (ja) * 1994-05-16 1996-02-06 Sumitomo Chem Co Ltd テトラゾール化合物の製造法
US6407101B1 (en) 1999-05-04 2002-06-18 American Home Products Corporation Cyanopyrroles
AU767762B2 (en) * 1999-05-04 2003-11-20 Wyeth Thio-oxindole derivatives
US6391907B1 (en) 1999-05-04 2002-05-21 American Home Products Corporation Indoline derivatives
KR100732692B1 (ko) * 1999-05-04 2007-06-27 와이어쓰 프로게스테론 수용체 조절인자인 시클로티오카르바메이트유도체
US6417214B1 (en) 1999-05-04 2002-07-09 Wyeth 3,3-substituted indoline derivatives
US6509334B1 (en) 1999-05-04 2003-01-21 American Home Products Corporation Cyclocarbamate derivatives as progesterone receptor modulators
UA73119C2 (en) * 2000-04-19 2005-06-15 American Home Products Corpoir Derivatives of cyclic thiocarbamates, pharmaceutical composition including noted derivatives of cyclic thiocarbamates and active ingredients of medicines as modulators of progesterone receptors
US7132445B2 (en) * 2001-04-16 2006-11-07 Schering Corporation 3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
JP2005535623A (ja) * 2002-06-25 2005-11-24 ワイス ホルモン関連症状の治療における、チオ−オキシインドール誘導体の使用
AU2003247608A1 (en) * 2002-06-25 2004-01-06 Wyeth Use of cyclothiocarbamate derivatives in treatment of hormone-related conditions
EP1531824A4 (en) * 2002-06-25 2005-09-21 Wyeth Corp CYCLOTHIOCARBAMATE DERIVATIVES AS PR-MODULATORS AND THEIR USE IN THE TREATMENT OF SKIN DISEASES
MXPA04012418A (es) * 2002-06-25 2005-04-19 Wyeth Corp Uso de derivados de tio-oxindol en tratamiento de trastornos de la piel.
EP1732921B1 (en) * 2004-04-08 2008-11-05 Wyeth Thioamide derivatives as progesterone receptor modulators
JP4950027B2 (ja) 2004-04-08 2012-06-13 ワイス・エルエルシー チオアミド不純物を最小限に抑えるための方法

Also Published As

Publication number Publication date
EP1732922A1 (en) 2006-12-20
CN1938298A (zh) 2007-03-28
ATE409699T1 (de) 2008-10-15
US20050228179A1 (en) 2005-10-13
CA2561313A1 (en) 2005-10-27
MXPA06011695A (es) 2006-12-14
ES2313334T3 (es) 2009-03-01
JP2007532581A (ja) 2007-11-15
DE602005010065D1 (de) 2008-11-13
US20080071083A1 (en) 2008-03-20
US7572824B2 (en) 2009-08-11
JP4950027B2 (ja) 2012-06-13
CN1938298B (zh) 2013-02-06
BRPI0509213A (pt) 2007-08-28
AU2005233648A1 (en) 2005-10-27
CA2561313C (en) 2012-12-04
AU2005233648B2 (en) 2011-06-23
PL1732922T3 (pl) 2009-03-31
EP1732922B1 (en) 2008-10-01
US7314932B2 (en) 2008-01-01
WO2005100347A1 (en) 2005-10-27

Similar Documents

Publication Publication Date Title
DE602005019899D1 (de) System zur behandlung von ischämischem schlaganfall
UY33981A (es) ?método para preparar compuestos macrocíclicos inhibidores de serina proteasas de hepatitis c?.
ATE543807T1 (de) Verstärker von glutamat-rezeptoren
EA201070247A1 (ru) Ингибиторы протеасом
EA200970605A1 (ru) Ингибиторы mapk/erk-киназ
ATE410430T1 (de) 2,3-dihydro-6-nitroimidazoä2,1- büoxazolverbindungen zur behandlung von tuberkulose
NO20083002L (no) Fremgangsmate for anvendelse av CD40-bindende forbindelser
DK1828164T3 (da) Fremgangsmåde til fremstilling af N-phenylpyrazol-1-carboxamider
ATE515261T1 (de) Zusammensetzungen zur behandlung von diabetes
DK1778668T3 (da) Fremgangsmåde til fremstilling af dihydropteridion
DE602004010234D1 (de) Verfahren zur herstellung von 4-aminodiphenylamin
DE602005026984D1 (de) Chinolin-derivate zur behandlung von latenter tuberkulose
DE602006013115D1 (de) Benzisoxazolpiperidinverbindungen und verfahren zu deren anwendung
EA200970407A1 (ru) Ингибиторы киназ mapk/erk
EA200970597A1 (ru) Новые бис(диалкиламиды), способ получения и применения
DE602005011416D1 (de) Schnell härtende polydiorganosiloxane
TW200604149A (en) Norbornane based cycloaliphatic compounds containing nitrile groups
ATE410166T1 (de) 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydrochinolin- derivate zur behandlung von unfruchtbarkeit
NO20060535L (no) Aztreonam-L-lysin og fremgangsmater for fremstilling av dette
DK1660485T3 (da) Forbedret fremgangsmåde til fremstilling af alpha-polymorfisk eletriptanhydrobromid
DK1663997T3 (da) 1h-azolyl-methyl-amider, fremgangsmåde til fremstilling deraf og anvendelse deraf som nitrifikationsinhibitorer
DK1692137T3 (da) Fremgangsmåde til fremstilling af tubulinininhibitorer
PL1732922T3 (pl) Sposób minimalizowania zanieczyszczeń tioamidowych
EP1791521A4 (en) METHODS OF ADMINISTERING PROPOFOL PROMOTERS WITH WATER SOLUBLE
DK1685104T3 (da) Fremgangsmåde til fremstilling af N-substituerede phthalomider